BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 11147993)

  • 21. Improvement of lipid profile is accompanied by atheroprotective alterations in high-density lipoprotein composition upon tumor necrosis factor blockade: a prospective cohort study in ankylosing spondylitis.
    van Eijk IC; de Vries MK; Levels JH; Peters MJ; Huizer EE; Dijkmans BA; van der Horst-Bruinsma IE; Hazenberg BP; van de Stadt RJ; Wolbink GJ; Nurmohamed MT
    Arthritis Rheum; 2009 May; 60(5):1324-30. PubMed ID: 19404933
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ASDAS, BASDAI and different treatment responses and their relation to biomarkers of inflammation, cartilage and bone turnover in patients with axial spondyloarthritis treated with TNFα inhibitors.
    Pedersen SJ; Sørensen IJ; Garnero P; Johansen JS; Madsen OR; Tvede N; Hansen MS; Thamsborg G; Andersen LS; Majgaard O; Loft AG; Erlendsson J; Asmussen K; Jurik AG; Møller J; Hasselquist M; Mikkelsen D; Skjødt T; Lambert R; Hansen A; Østergaard M
    Ann Rheum Dis; 2011 Aug; 70(8):1375-81. PubMed ID: 21551511
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum insulin/like growth factor I, bone mineral density and biochemical markers of bone metabolism in children with idiopathic osteoporosis.
    Chlebna-Sokol D; Rusinska A
    Endocr Regul; 2001 Dec; 35(4):201-8. PubMed ID: 11858767
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of tumor necrosis factor-alpha with early target organ damage in newly diagnosed patients with essential hypertension.
    Navarro-González JF; Mora C; Muros M; Jarque A; Herrera H; García J
    J Hypertens; 2008 Nov; 26(11):2168-75. PubMed ID: 18854757
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The unmet need for anti-tumour necrosis factor (anti-TNF) therapy in ankylosing spondylitis.
    Barkham N; Kong KO; Tennant A; Fraser A; Hensor E; Keenan AM; Emery P
    Rheumatology (Oxford); 2005 Oct; 44(10):1277-81. PubMed ID: 16105913
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adipose tissue, serum adipokines, and ghrelin in patients with ankylosing spondylitis.
    Toussirot E; Streit G; Nguyen NU; Dumoulin G; Le Huédé G; Saas P; Wendling D
    Metabolism; 2007 Oct; 56(10):1383-9. PubMed ID: 17884449
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ankylosing spondylitis, psoriatic arthritis, and reactive arthritis show increased bone resorption, but differ with regard to bone formation.
    Grisar J; Bernecker PM; Aringer M; Redlich K; Sedlak M; Wolozcszuk W; Spitzauer S; Grampp S; Kainberger F; Ebner W; Smolen JS; Pietschmann P
    J Rheumatol; 2002 Jul; 29(7):1430-6. PubMed ID: 12136902
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum TNF-alpha levels are increased and correlate negatively with free IGF-I in Alzheimer disease.
    Alvarez A; Cacabelos R; Sanpedro C; García-Fantini M; Aleixandre M
    Neurobiol Aging; 2007 Apr; 28(4):533-6. PubMed ID: 16569464
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of the selective oestrogen receptor modulator (raloxifene hydrochloride) on IL-6, TNF-alpha, TGF-beta1 and bone turnover markers in the treatment of postmenopausal osteoporosis.
    Ozmen B; Kirmaz C; Aydin K; Kafesciler SO; Guclu F; Hekimsoy Z
    Eur Cytokine Netw; 2007 Sep; 18(3):148-53. PubMed ID: 17823083
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Elevated triglycerides and low levels of high-density lipoprotein as markers of disease activity in association with up-regulation of the tumor necrosis factor alpha/tumor necrosis factor receptor system in systemic lupus erythematosus.
    Svenungsson E; Gunnarsson I; Fei GZ; Lundberg IE; Klareskog L; Frostegård J
    Arthritis Rheum; 2003 Sep; 48(9):2533-40. PubMed ID: 13130473
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Elevated serum concentration of hepatocyte growth factor in patients with multiple myeloma: correlation with markers of disease activity.
    Alexandrakis MG; Passam FH; Sfiridaki A; Kandidaki E; Roussou P; Kyriakou DS
    Am J Hematol; 2003 Apr; 72(4):229-33. PubMed ID: 12666132
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protein oxidation status in patients with ankylosing spondylitis.
    Yazici C; Köse K; Calis M; Kuzugüden S; Kirnap M
    Rheumatology (Oxford); 2004 Oct; 43(10):1235-9. PubMed ID: 15292529
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytokine production from peripheral blood mononuclear cells in patients with ankylosing spondylitis and their first-degree relatives.
    Chou CT; Huo AP; Chang HN; Tsai CY; Chen WS; Wang HP
    Arch Med Res; 2007 Feb; 38(2):190-5. PubMed ID: 17227728
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased expression of Toll-like receptor 4 in peripheral blood leucocytes and serum levels of some cytokines in patients with ankylosing spondylitis.
    Yang ZX; Liang Y; Zhu Y; Li C; Zhang LZ; Zeng XM; Zhong RQ
    Clin Exp Immunol; 2007 Jul; 149(1):48-55. PubMed ID: 17459079
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characteristics and treatment responses of patients satisfying the BSR guidelines for anti-TNF in ankylosing spondylitis.
    Gadsby K; Deighton C
    Rheumatology (Oxford); 2007 Mar; 46(3):439-41. PubMed ID: 17255137
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of simvastatin on serum cytokine levels and bone metabolism in postmenopausal subjects: negative correlation between TNF-alpha and anabolic bone parameters.
    Tikiz C; Unlü Z; Tikiz H; Ay K; Angin A; Onur E; Var A; Tüzün C
    J Bone Miner Metab; 2004; 22(4):365-71. PubMed ID: 15221496
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interleukin 1beta (IL-1beta), IL-10, tumor necrosis factor-alpha, and cellular proliferation index in peripheral blood mononuclear cells in patients with ankylosing spondylitis.
    Vazquez-Del Mercado M; Garcia-Gonzalez A; Muñoz-Valle JF; Garcia-Iglesias T; Martinez-Bonilla G; Bernard-Medina G; Sanchez-Ortiz A; Ornelas-Aguirre JM; Salazar-Paramo M; Gamez-Nava JI; Gonzalez-Lopez L
    J Rheumatol; 2002 Mar; 29(3):522-6. PubMed ID: 11908566
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of circulating levels of inflammatory and bone formation markers in axial spondyloarthritis.
    de Andrade KR; de Castro GR; Vicente G; da Rosa JS; Nader M; Pereira IA; Fröde TS
    Int Immunopharmacol; 2014 Aug; 21(2):481-6. PubMed ID: 24925756
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased levels of soluble TNF-like cytokine 1A in ankylosing spondylitis.
    Konsta M; Bamias G; Tektonidou MG; Christopoulos P; Iliopoulos A; Sfikakis PP
    Rheumatology (Oxford); 2013 Mar; 52(3):448-51. PubMed ID: 23204549
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of a quantitative scoring of enthesitis in ankylosing spondylitis.
    Kaya A; Ozgocmen S; Kamanli A; Aydogan R; Yildirim A; Ardicoglu O
    J Clin Rheumatol; 2007 Dec; 13(6):303-6. PubMed ID: 18176136
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.